EA201270727A1 - Пуриновые соединения - Google Patents

Пуриновые соединения

Info

Publication number
EA201270727A1
EA201270727A1 EA201270727A EA201270727A EA201270727A1 EA 201270727 A1 EA201270727 A1 EA 201270727A1 EA 201270727 A EA201270727 A EA 201270727A EA 201270727 A EA201270727 A EA 201270727A EA 201270727 A1 EA201270727 A1 EA 201270727A1
Authority
EA
Eurasian Patent Office
Prior art keywords
purine
connections
compound
formula
pharmaceutical compositions
Prior art date
Application number
EA201270727A
Other languages
English (en)
Other versions
EA020565B1 (ru
Inventor
Шон Патрик Холлинсхед
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201270727A1 publication Critical patent/EA201270727A1/ru
Publication of EA020565B1 publication Critical patent/EA020565B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Соединение формулыи фармацевтические композиции для лечения боли.
EA201270727A 2010-03-31 2011-03-30 Пуриновые соединения EA020565B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31953210P 2010-03-31 2010-03-31
PCT/US2011/030412 WO2011123482A1 (en) 2010-03-31 2011-03-30 Purine compounds used as cb2 agonists

Publications (2)

Publication Number Publication Date
EA201270727A1 true EA201270727A1 (ru) 2013-01-30
EA020565B1 EA020565B1 (ru) 2014-12-30

Family

ID=43902609

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270727A EA020565B1 (ru) 2010-03-31 2011-03-30 Пуриновые соединения

Country Status (12)

Country Link
US (1) US8710063B2 (ru)
EP (1) EP2552916B1 (ru)
JP (1) JP5674918B2 (ru)
KR (1) KR101432411B1 (ru)
CN (1) CN102803263B (ru)
AU (1) AU2011235290B2 (ru)
BR (1) BR112012024587A2 (ru)
CA (1) CA2795006C (ru)
EA (1) EA020565B1 (ru)
ES (1) ES2481867T3 (ru)
MX (1) MX2012011164A (ru)
WO (1) WO2011123482A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9067943B2 (en) 2011-11-25 2015-06-30 Hoffmann-La Roche Inc. [1,2,3]triazolo[4,5-D]pyrimidine derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60260579A (ja) 1984-01-13 1985-12-23 Yoshitomi Pharmaceut Ind Ltd プリン誘導体
IL87149A (en) 1987-07-20 1994-05-30 Merck & Co Inc 6-Piperazinyl derivatives of purine and its 3- and 9-deaza isosteres, their preparation and pharmaceutical compositions containing them
WO2003022214A2 (en) 2001-09-06 2003-03-20 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
US20030139427A1 (en) 2002-08-23 2003-07-24 Osi Pharmaceuticals Inc. Bicyclic pyrimidinyl derivatives and methods of use thereof
US7129239B2 (en) * 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
WO2005067546A2 (en) 2004-01-13 2005-07-28 Ambit Biosciences Corporation Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
WO2006128172A2 (en) 2005-05-26 2006-11-30 Synta Pharmaceuticals Corp. Method for treating b cell regulated autoimmune disorders
WO2010019762A1 (en) 2008-08-13 2010-02-18 Jenrin Discovery Purine compounds as cannabinoid receptor blockers
UA104010C2 (en) * 2008-12-18 2013-12-25 Эли Лилли Энд Компани Purine compounds

Also Published As

Publication number Publication date
ES2481867T3 (es) 2014-07-31
JP5674918B2 (ja) 2015-02-25
JP2013523755A (ja) 2013-06-17
CA2795006C (en) 2014-05-13
EA020565B1 (ru) 2014-12-30
KR101432411B1 (ko) 2014-08-20
MX2012011164A (es) 2012-11-12
KR20130006642A (ko) 2013-01-17
EP2552916A1 (en) 2013-02-06
EP2552916B1 (en) 2014-05-21
AU2011235290B2 (en) 2013-12-05
BR112012024587A2 (pt) 2016-05-31
WO2011123482A1 (en) 2011-10-06
CA2795006A1 (en) 2011-10-06
US8710063B2 (en) 2014-04-29
US20120329809A1 (en) 2012-12-27
CN102803263A (zh) 2012-11-28
AU2011235290A1 (en) 2012-09-06
CN102803263B (zh) 2014-12-17

Similar Documents

Publication Publication Date Title
EA201170832A1 (ru) Пуриновые соединения
CR20130045A (es) Compuestos terapéuticos
CY1118187T1 (el) Χημικες ενωσεις
PH12016500024A1 (en) Bromodomain inhibitor
EA201890239A2 (ru) Фумараты как пролекарства и их применение при лечении различных заболеваний
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201391626A1 (ru) Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
EA201300730A1 (ru) Производные индазолилтриазола
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
EA201300684A1 (ru) Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
EA201400412A1 (ru) ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
EA201270254A1 (ru) Производные 5-фторпиримидинона
CR20120295A (es) Triazolopiridinas
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
UA109667C2 (xx) Похідні хіназолін-4(3h)-ону, що використовуються як інгібітори pi3-кінази
CR20130539A (es) Triazolopiridinas
CR20120637A (es) Triazolopiridinas sustituidas
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU